Ranbaxy Laboratories Ltd. - Research Center

---

	Dec ' 08	Dec ' 07	Dec ' 06	Dec ' 05	Dec ' 04
Sources of funds
Owner's fund
Equity share capital	210.19	186.54	186.34	186.22	185.89
Share application money	175.66	1.18	0.88	0.28	2.83
Preference share capital	-	-	-	-	-
Reserves & surplus	3,330.92	2,350.68	2,162.79	2,190.80	2,320.79
Loan funds
Secured loans	162.07	365.07	224.29	353.49	133.37
Unsecured loans	3,563.30	3,137.96	2,954.31	676.31	2.49
Total	7,442.14	6,041.42	5,528.61	3,407.10	2,645.38
Uses of funds
Fixed assets
Gross block	2,386.75	2,261.48	2,133.57	1,799.32	1,402.79
Less : revaluation reserve	-	-	-	-	-
Less : accumulated depreciation	930.07	791.96	699.54	599.35	525.21
Net block	1,456.68	1,469.52	1,434.03	1,199.97	877.58
Capital work-in-progress	428.77	327.42	301.88	432.84	264.16
Investments	3,618.03	3,237.55	2,679.95	762.78	679.07
Net current assets
Current assets, loans & advances	6,509.97	2,922.42	2,620.99	2,409.08	2,366.89
Less : current liabilities & provisions	4,571.31	1,915.49	1,508.24	1,397.56	1,542.33
Total net current assets	1,938.67	1,006.93	1,112.76	1,011.52	824.57
Miscellaneous expenses not written	-	-	-	-	-
Total	7,442.14	6,041.42	5,528.61	3,407.10	2,645.38
Notes:
Book value of unquoted investments	3,372.60	3,106.69	2,659.94	762.77	679.07
Market value of quoted investments	-	280.46	14.27	0.01	0.01
Contingent liabilities	252.85	201.00	159.40	202.40	307.95
Number of equity sharesoutstanding (Lacs)	4203.70	3730.71	3726.87	3724.42	1858.91

© Copyright 2009 Rediff.com India Limited. All rights reserved. DisclaimerTerms of ServicePrivacy PolicyFeedback